A panelist discusses how glucagon-like peptide-1 receptor (GLP-1) agonists' cardioprotective effects likely stem from multiple physiological mechanisms, including reduced inflammation, improved ...
Innovations in rare blood disorders took center stage at the 2024 American Society of Hematology (ASH) Annual Meeting & ...
Alice W. Lee, PhD, MPH, of California State University, Fullerton, discusses her study on ovarian cancer survival disparities ...
Patients with ER-positive/HER2-negative metastatic breast cancer who received elacestrant experienced a significant reduction ...
War-related psychological stress was associated with increased MRI-detected disease activity in patients with multiple ...
Patients with dry eye associated with contact lenses had significant improvement in visual acuity and their Ocular Surface ...
Komal Jhaveri, MD, FACP, breast oncologist and early drug development specialist at Memorial Sloan Kettering Cancer Center, ...
Yi Lin, MD, PhD, hematologist and oncologist, Mayo Clinic, discusses the efficacy of ciltacabtagene autoleucel (cilta-cel) chimeric antigen receptor T-cell therapy vs standard treatments for patients ...
Bispecific antibodies show strong initial uptake in community settings for multiple myeloma treatment, particularly among ...
Conventional parameters for risk stratification prognosis for patients with low-risk myelodysplastic neoplasms, especially ...
Novel strategies in the VISIBLE trial set a new standard for recruiting and retaining diverse participants with skin of color ...
The recommendations for surveillance account for newly identified hematopoietic malignancy predispositions (HMP) and HMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback